 SAN DIEGO, Sept. 10, 2021 PRNewswire -- Neurocrine Biosciences, Inc. Nasdaq: NBIX today announced that it will present new data from its movement disorder treatments for tardive dyskinesia TD and Parkinsons disease at the International Parkinson and Movement Disorder Societys MDS Virtual Congress 2021 being held September 1722, 2021. 